做多
Possible Long Targets Set For SBBP
Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.
SHORT INTEREST
1.13M 08/15/19
Average Recommendation: BUY
Average Target Price: 13.71
P/E Current
7.53
P/E Ratio (with extraordinary items)
6.21
P/E Ratio (without extraordinary items)
6.51
SHORT INTEREST
1.13M 08/15/19
Average Recommendation: BUY
Average Target Price: 13.71
P/E Current
7.53
P/E Ratio (with extraordinary items)
6.21
P/E Ratio (without extraordinary items)
6.51
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。